Coronavirus COVID-19 Updates: uc.edu/publichealth
The Department of Psychiatry and Behavioral Neurosciences is dependent on philanthropic support. Below is a list of funding priorities.
If you would like to make a gift now to support any of these funds CLICK HERE. In the new window when selecting the area to support click the "Search all Funds" button on the far right and type in the name of your preferred fund below and then click Donate Now at the bottom of the page. If you would like to explore other giving opportunities, please contact Abby Elsenor at (513) 558-5479 or firstname.lastname@example.org
Specifically supports research into prevention, treatment and education of substance use disorders.
Specifically supports new treatments for Bipolar Disorder and novel methods to clarify the neurobiology of bipolar disorder. Our ultimate goal is to improve the outcome of children, adolescents and adults with Bipolar Disorder.
Specifically supports education in geriatric psychiatry for residents, fellows and faculty.
The goal of the Post Traumatic Stress Disorder Program (PTSD) is to deliver Accelerated Resolution Therapy (ART) and Cognitive Processing Therapy (CPT) treatments to civilians and military veterans with stress-related illness and to compare their efficacy for the treatment of PTSD related to various traumas.
The purpose of this fund is to maintain scientific and clinical excellence within the Department of Psychiatry. Funds will specifically support the visiting professors program and our residents/fellows scholarly presentations at regional/national conferences.
The purpose of this fund is to support recruitment and scholarly activity of the Family Medicine/Psychiatry residents.
The purpose of this fund is to support resident/fellow scholarly activity in the area of child and adolescent psychiatry.
Specifically supports the most advanced methods to diagnose and treat adult and adolescent patients with depression, bipolar spectrum disorder, anxiety disorders, cyclothymia and dysthymia.
The goals of the Schizophrenia Program are to generate new knowledge about the neurobiology and psychopharmacology of schizophrenia and related psychotic disorders. Both animal and human research projects are conducted and new medications with novel mechanisms of action for the treatment of schizophrenia are tested for efficacy and safety. The program also provides education to health professionals and the public and provides clinical consultations to community psychiatrists about treatment-resistant patients with psychosis.
Stetson Building Suite 3200260 Stetson Street PO Box 670559Cincinnati, OH 45267-0559